Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist

Fertility and Sterility

Volumn 96, Issue 1, 2011, Pages 63-68

  Kummer, Nicole ^a   Benadiva, Claudio ^a   Feinn, Richard ^b   Mann, Jessica ^a   Nulsen, John ^a   Engmann, Lawrence ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Estradiol; GnRH agonist; GnRH antagonist; ICSI; IVF; LH

Indexed keywords

ESTRADIOL; GANIRELIX; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; NIDATION; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; MALE; OOCYTES; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 79959915609     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.04.050     Document Type: Article

References (28)

1. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
2. S. Kol Luteolysis induced by gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil Steril 81 2004 1 5 (Pubitemid 38058315)
3. B. Acevedo, J. Gomez-Palomares, E. Ricciarelli, and E. Hernández Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil Steril 86 2006 1682 1687 (Pubitemid 44781379)
4. A. DiLuigi, L. Engmann, D. Schmidt, D. Maier, J. Nulsen, and C. Benadiva Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting Fertil Steril 94 2010 1111 1114
5. P. Humaidan, H.E. Bredkjaer, L. Bungum, M.L. Grondahl, L. Westergaard, and C.Y. Anderson GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220 (Pubitemid 40796107)
6. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892 (Pubitemid 41508652)
7. E. Kolibianakis, C. Albano, J. Kahn, M. Camus, H. Tournaye, and A. Van Steirteghem Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy Fertil Steril 79 2003 873 880 (Pubitemid 36385006)
8. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715 (Pubitemid 34158241)
9. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192 (Pubitemid 37158033)
10. L. Engmann, L. Siano, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod Biomed Online 13 2006 639 644 (Pubitemid 44760886)
11. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
12. E. Papanikolaou, C. Pozzobon, E. Kolibianakis, M. Camus, H. Tournaye, and H. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120 (Pubitemid 43063432)
13. Z. Rosenwaks Donor eggs: their approach in modern reproductive technologies Fertil Steril 47 1987 895 909 (Pubitemid 17089228)
14. S. Kol, and J. Itskovitz-Eldor Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome - a 20-year experience Semin Reprod Med 28 2010 500 505
15. A. Sismanoglu, H. Tekin, H. Erden, N. Ciray, U. Ulug, and M. Bahceci Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial J Assist Reprod Genet 26 2009 251 256
16. A. Galindo, D. Bodri, J. Guillen, M. Colodron, and V. Vernaeve Triggering with hCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomized clinical trial Gynecol Endocrinol 25 2009 60 66
17. M. Melo, C. Buss, J. Bellver, P. Alama, N. Garrido, and M. Meseguer GnRH agonist versus recombinant hCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study Reprod Biomed Online 19 2009 486 492
18. G. Griesinger, E.M. Kolibianakis, E.G. Papanikolaou, K. Diedrich, A. Van Steirteghem, and P. Devroey Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin: live birth after frozen-thawed embryo replacement cycles Fertil Steril 88 2007 616 621 (Pubitemid 47368245)
19. T. Eldar-Geva, E. Zylber-Haran, R. Babayof, T. Halevy-Shalem, A. Ben-Chetrit, and A. Tsafrir Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist GnRH-antagonist/hCG or long protocol ovarian stimulation Reprod Biomed Online 14 2007 148 154 (Pubitemid 46296496)
20. R. Short Steroids in the follicular fluid and the corpus luteum of the mare: a "two-cell type" theory of ovarian steroid synthesis J Endocrinol 24 1962 59 63
21. D. Armstrong, and H. Papkoff Stimulation of aromatization of exogenous androgens in ovaries of hypophysectomized rats in vivo by follicle-stimulating hormone Endocrinology 99 1976 1144 1151
22. J.S. Richards Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation Physiol Rev 60 1980 51 89 (Pubitemid 10104511)
23. E. Papanikolaou, P. Humaidan, N. Polyzos, and B. Tarlatzis Identification of the high-risk patient for ovarian hyperstimulation syndrome Semin Reprod Med 28 2010 458 462
24. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil Steril 90 2008 231 233 (Pubitemid 351885203)
25. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose hCG: a pilot study Reprod Biomed Online 18 2009 630 634
26. P. Humaidan, H. Ejdrup Bredkjaer, L. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
27. J. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. Casan, and F. Bonilla-Musoles Cycles triggered with GnRH agonist: exploring low-dose hCG for luteal support Reprod Biomed Online 20 2010 175 181
28. E. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil Steril 95 2011 1174 1177